HERON THERAPEUTICS, INC. /DE/ Cash and Restricted Cash
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Cash and Restricted Cash of $20.72 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.72M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26.12M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28.65M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $43.07M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $20.72M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $26.12M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $28.65M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $43.07M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $16.52M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $19.27M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $25.80M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $25.74M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $18.39M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $20.45M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $28.68M 10-K · filed 2026-02-26 |
| 2023-09-30 | $34.86M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $13.46M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $27.09M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $15.36M 10-K · filed 2026-02-26 |
| 2022-09-30 | $50.44M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $48.61M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $56.91M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $90.54M 10-K · filed 2025-02-27 |
| 2021-09-30 | $159.57M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $191.17M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $59.74M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $105.14M 10-K · filed 2023-03-29 |
| 2020-09-30 | $95.14M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $80.73M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $103.28M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $71.90M 10-K · filed 2022-02-28 |
| 2019-09-30 | $60.11M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $53.04M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $23.46M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $31.84M 10-K · filed 2022-02-28 |
| 2018-09-30 | $53.93M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $144.58M 10-K · filed 2021-02-24 |
| 2016-12-31 | $13.41M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |